Effect of timing of intravenous administration of myelin basic protein on the induction of tolerance in experimental allergic encephalomyelitis.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Multiple Sclerosis

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1191/135245899701564308PMID 10096096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

  1998cited by this paper
• Tolerance Induction and Autoimmune Encephalomyelitis Amelioration After Administration of Myelin Basic Protein–derived Peptide

  1997cited by this paper
• Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives.

  1997cited by this paper
• The effect of intrathecal MBP synthetic peptides containing epitope P85 VVHFFKNIVTP96 on free anti-MBP levels in acute relapsing multiple sclerosis.

  1997cited by this paper
• Interferon-beta inhibits progression of relapsing-remitting experimental autoimmune encephalomyelitis.

  1996cited by this paper
• Intravenous antigen adrmnistration as a therapy for autoimmune demyelinating disease

  1996cited by this paper
• Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group.

  1995cited by this paper
• Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in lewis rats: Dynamics of cellular mrna expression in the central nervous system and lymphoid cells

  1995cited by this paper
• Administration of myelin basic protein synthetic peptides to multiple sclerosis patients.

  1995cited by this paper
• Antigen-dependent clonal expansion of a trace population of antigen-specific CD4+ T cells in vivo is dependent on CD28 costimulation and inhibited by CTLA-4.

  1995cited by this paper
• The B7 and CD28 receptor families.

  1994cited by this paper
• The ups and downs of T cell costimulation.

  1994cited by this paper
• Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis.

  1994cited by this paper
• Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production

  1994cited by this paper
• T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis.

  1994cited by this paper
• Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis

  1993cited by this paper
• The role of the CD28 receptor during T cell responses to antigen.

  1993cited by this paper
• Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes.

  1993cited by this paper
• Amelioration of autoimmune encephalomyelitis by myelin basic protein synthetic peptide-induced anergy.

  1992cited by this paper
• Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats.

  1992cited by this paper
• Immunological aspects of demyelinating diseases.

  1992cited by this paper
• Myelin basic protein infused into cerebrospinal fluid suppresses experimental autoimmune encephalomyelitis.

  1991cited by this paper
• Successful treatment of paralytic relapses in adoptive experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance.

  1991cited by this paper
• Antigen-driven bystander suppression after oral administration of antigens

  1991cited by this paper
• Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

  1991cited by this paper
• Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy.

  1991cited by this paper
• Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases

  1991cited by this paper
• Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.

  1989cited by this paper
• Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.

  1988cited by this paper
• Antigen presentation by chemically modified splenocytes induces antigen- specific T cell unresponsiveness in vitro and in vivo

  1987cited by this paper
• Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.

  1987cited by this paper
• Immunoregulation of experimental allergic encephalomyelitis: conditions for induction of suppressor cells and analysis of mechanism.

  1977cited by this paper
• THE MAJOR SITE OF GUINEA‐PIG MYELIN BASIC PROTEIN ENCEPHALITOGENIC IN LEWIS RATS 1 2

  1977cited by this paper
• Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis.

  1975cited by this paper
• Suppression by several synthetic polypeptides of experimental allergic encephalomyelitis induced in guinea pigs and rabbits with bovine and human basic encephalitogen

  1973cited by this paper
• Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

  1972cited by this paper
• Allergic encephalomyelitis: immunologically specific inhibition of cellular passive transfer by encephalitogenic basic proteins.

  1970cited by this paper
• Allergic Encephalomyelitis: Passive Transfer Prevented by Encephalitogen

  1968cited by this paper

• A Recombinant Acetylcholine Receptor α1 Subunit Extracellular Domain Is a Promising New Drug Candidate for Treatment Of Myasthenia Gravis

  2022cites this paper
• Experimental Autoimmune Encephalomyelitis Is Successfully Controlled by Epicutaneous Administration of MOG Plus Vitamin D Analog

  2017cites this paper
• Treatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis

  2015cites this paper
• Emerging immunopharmacological targets in multiple sclerosis.

  2015cites this paper
• Mechanisms of immunological tolerance in central nervous system inflammatory demyelination

  2015cites this paper
• T-cell based immunotherapy in experimental autoimmune encephalomyelitis and multiple sclerosis.

  2010cites this paper
• CD11c+CD11b+ Dendritic Cells Play an Important Role in Intravenous Tolerance and the Suppression of Experimental Autoimmune Encephalomyelitis1

  2008cites this paper
• This information is current as Autoimmune Encephalomyelitis the Suppression of Experimental andImportant Role in Intravenous Tolerance Dendritic Cells Play an + CD 11 b + CD 11 c

  2008cites this paper
• Tolerance Dependent on Timing/Amount of Antigen-Dose in an Asymmetric Idiotypic Network

  2006cites this paper
• The protease inhibitor, Bowman-Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis

  2006cites this paper
• Immunomodulation of EAE: Altered Peptide Ligands, Tolerance, and Th1/Th2

  2005cites this paper
• A paradoxical role of APCs in the induction of intravenous tolerance in experimental autoimmune encephalomyelitis.

  2005cites this paper
• Induces Type 1 Regulatory T Cells Smith Proteins Postpones Murine Lupus and Intravenous Injection of a D1 Protein of the

  2004cites this paper
• Intravenous Injection of a D1 Protein of the Smith Proteins Postpones Murine Lupus and Induces Type 1 Regulatory T Cells1

  2004cites this paper
• This information is current as Autoimmune Encephalomyelitis Intravenous Tolerance in Experimental The Role of IL-12 in the Induction of and

  2002cites this paper
• Antigen-specific antibodies in cerebrospinal fluid after intramuscular injection of ovalbumin in horses.

  2002cites this paper
• The Role of IL-12 in the Induction of Intravenous Tolerance in Experimental Autoimmune Encephalomyelitis1

  2002cites this paper
• A role for TGFbeta and B cells in immunologic tolerance after intravenous injection of soluble antigen.

  2001cites this paper
• A gene therapy approach for treating T-cell-mediated autoimmune diseases.

  2001cites this paper
• Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.

  2000cites this paper